Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bliv vs Southern Vitality and Weight Loss

Bliv
Graded #187

Higher grade

vs+1.0999999999999943
Southern Vitality and Weight Loss
Graded #227

Lower grade

The verdict

Bliv takes it — 66.3/100 to 65.2/100, but only just.

Bliv grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bliv is a telehealth provider selling personalised compounded GLP-1 programmes. Southern Vitality and Weight Loss is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBliv +17
71
54
Dose & formulationEven
64
64
Clinical oversightSouthern Vitality and Weight Loss +5
82
87
Labs & monitoringSouthern Vitality and Weight Loss +1
53
54
FulfillmentSouthern Vitality and Weight Loss +6
65
71
Contract termsSouthern Vitality and Weight Loss +16
45
61
Bliv · left barSouthern Vitality and Weight Loss · right bar

The numbers

MetricBlivSouthern Vitality and Weight Loss
WeighScore66.3/10065.2/100
GradeCC
Scorecard rank#187#227
Semaglutide$116/mo (as low as, varies by plan and eligibility, compounded)$199/mo (compounded)
Tirzepatide$199/mo (as low as, varies by plan and eligibility, compounded)$299/mo (compounded)
CoverageCoverage not published1 state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Bliv

Graded #187 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • The advertised rates are 'as low as' figures footnoted 'based on plan structure and eligibility', and the plan selector sits behind the medical intake — the rate you are offered is not knowable before you hand over a medical history
  • A $24.99 provider consultation fee is charged on top, and the refund policy deducts $200 for 'clinical coordination and account setup'
  • The homepage advertises 'no long-term commitments or cancellation fees' while the terms require the membership fee to be paid 'in a single sum', call it non-refundable and refer to a 'Membership Term'
  • The only figure smaller than the advertised rate is a $29 CareCredit/Klarna instalment, which is a financing payment rather than the price of a month of medication
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Strengths

  • Compounded GLP-1 (semaglutide and tirzepatide) starting as low as $99/mo
  • Names its compounding pharmacy partners (PerfectRx, The Pharmacy Hub, RX Compound Store) — uncommon transparency
  • Free telehealth consult and free shipping; no membership or hidden fees
  • Bi-weekly check-ins; operating since 2012
  • Flexible monthly financing available at checkout

Where it loses points

  • This is one physical clinic in Valdosta, Georgia, not a national telehealth service — nothing here is available to a reader outside Georgia
  • The advertised 'as low as $99/month' is a semaglutide three-month starter pack ($299 paid up front), not a tirzepatide rate and not a monthly one
  • Month-to-month rates are $199 semaglutide and $299 tirzepatide
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard